Equifax Inc
NYSE:EFX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
216.2
306.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Equifax Inc
Wall Street
Price Targets
EFX Price Targets Summary
Equifax Inc
According to Wall Street analysts, the average 1-year price target for
EFX
is 320.01 USD
with a low forecast of 274.72 USD and a high forecast of 399 USD.
EFX Last Price Targets
Equifax Inc
The latest public price target was made on Oct 11, 2024 by
Arthur Truslove
from
Citigroup
,
who expects
EFX
stock to
rise by 27%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Arthur Truslove
Citigroup
|
331
USD
Upside 27% |
2 months ago
Oct 11, 2024
|
Equifax (EFX) PT Raised to $331 at Citi
StreetInsider
|
Andrew Grobler
BNP Paribas
|
310
USD
Upside 19% |
3 months ago
Sep 19, 2024
|
Equifax upgraded to Neutral from Underperform at Exane BNP Paribas
TheFly
|
Manav Patnaik
Barclays
|
380
USD
Upside 45% |
3 months ago
Sep 13, 2024
|
Equifax price target raised to $380 from $300 at Barclays
TheFly
|
|
Toni Kaplan
New Street
|
271
USD
Upside 4% |
3 months ago
Sep 12, 2024
|
Equifax price target raised to $271 from $250 at Morgan Stanley
TheFly
|
Kyle Peterson
Needham
|
350
USD
Upside 34% |
3 months ago
Aug 28, 2024
|
Equifax (EFX) PT Raised to $350 at Needham, Top Pick, Remains on Needham's Conviction List
StreetInsider
|
Jason Haas
Wells Fargo
|
340
USD
Upside 30% |
4 months ago
Aug 12, 2024
|
Equifax initiated with an Overweight at Wells Fargo
TheFly
|
|
Kyle Peterson
Needham
|
320
USD
Upside 22% |
5 months ago
Jul 19, 2024
|
Equifax price target raised to $320 from $305 at Needham
TheFly
|
Shlomo Rosenbaum
Stifel Nicolaus
|
305
USD
Upside 17% |
5 months ago
Jul 19, 2024
|
Equifax price target raised to $305 from $265 at Stifel
TheFly
|
Owen Lau
Oppenheimer
|
300
USD
Upside 15% |
5 months ago
Jul 19, 2024
|
Equifax (EFX) PT Raised to $300 at Oppenheimer
StreetInsider
|
David Togut
Evercore ISI
|
305
USD
Upside 17% |
5 months ago
Jul 18, 2024
|
Equifax price target raised to $305 from $290 at Evercore ISI
TheFly
|
George Tong
Goldman Sachs
|
277
USD
Upside 6% |
5 months ago
Jul 18, 2024
|
Equifax price target raised to $277 from $246 at Goldman Sachs
TheFly
|
|
Shlomo Rosenbaum
Stifel Nicolaus
|
265
USD
Upside 1% |
8 months ago
Apr 19, 2024
|
Equifax (EFX) PT Lowered to $265 at Stifel
StreetInsider
|
|
Owen Lau
Oppenheimer
|
272
USD
Upside 4% |
8 months ago
Apr 19, 2024
|
Equifax (EFX) PT Lowered to $272 at Oppenheimer
StreetInsider
|
Jeffrey Meuler
Robert W. Baird
|
260
USD
Downside 0% |
8 months ago
Apr 19, 2024
|
Equifax (EFX) PT Lowered to $260 at Baird
StreetInsider
|
Toni Kaplan
Morgan Stanley
|
240
USD
Downside 8% |
8 months ago
Apr 18, 2024
|
Equifax (EFX) PT Raised to $240 at Morgan Stanley
StreetInsider
|
|
Shlomo Rosenbaum
Stifel Nicolaus
|
295
USD
Upside 13% |
8 months ago
Apr 9, 2024
|
Equifax (EFX) PT Raised to $295 at Stifel
StreetInsider
|
Faiza Alwy
Deutsche Bank
|
267
USD
Upside 2% |
1 year ago
Dec 7, 2023
|
Deutsche Bank Upgrades Equifax (EFX) to Buy
StreetInsider
|
Ashish Sabadra
RBC Capital
|
205
USD
Downside 22% |
1 year ago
Apr 21, 2023
|
These Analysts Revise Price Targets On Equifax Following Upbeat Q1 Results
Benzinga
|
Unknown Analyst
Truist Financial
|
260
USD
Downside 0% |
1 year ago
Feb 6, 2023
|
Truist Securities Maintains Buy on Equifax, Raises Price Target to $260
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EFX's stock price target?
Price Target
320.01
USD
According to Wall Street analysts, the average 1-year price target for
EFX
is 320.01 USD
with a low forecast of 274.72 USD and a high forecast of 399 USD.
What is Equifax Inc's Revenue forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Equifax Inc's revenue is
9%.
The projected
CAGR
for the next 4 years is
10%.
What is Equifax Inc's Operating Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Equifax Inc's operating income is
4%.
The projected
CAGR
for the next 4 years is
21%.
What is Equifax Inc's Net Income forecast?
Projected CAGR
36%
For the last 8 years the
compound annual growth rate for
Equifax Inc's net income is
3%.
The projected
CAGR
for the next 4 years is
36%.
You don't have any saved screeners yet
